Wells Fargo’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $286 | Buy |
68
+33
| +94% | +$139 | ﹤0.01% | 5959 |
|
2025
Q1 | $167 | Hold |
35
| – | – | ﹤0.01% | 5870 |
|
2024
Q4 | $133 | Sell |
35
-300
| -90% | -$1.14K | ﹤0.01% | 5890 |
|
2024
Q3 | $3K | Hold |
335
| – | – | ﹤0.01% | 5599 |
|
2024
Q2 | $3.26K | Sell |
335
-526
| -61% | -$5.12K | ﹤0.01% | 5557 |
|
2024
Q1 | $11.7K | Buy |
861
+603
| +234% | +$8.18K | ﹤0.01% | 5328 |
|
2023
Q4 | $2.82K | Buy |
258
+2
| +0.8% | +$22 | ﹤0.01% | 5598 |
|
2023
Q3 | $2.62K | Hold |
256
| – | – | ﹤0.01% | 5676 |
|
2023
Q2 | $4.03K | Sell |
256
-8
| -3% | -$126 | ﹤0.01% | 5799 |
|
2023
Q1 | $5.97K | Buy |
264
+10
| +4% | +$226 | ﹤0.01% | 5684 |
|
2022
Q4 | $9.07K | Sell |
254
-85
| -25% | -$3.03K | ﹤0.01% | 5263 |
|
2022
Q3 | $13K | Sell |
339
-26
| -7% | -$997 | ﹤0.01% | 5242 |
|
2022
Q2 | $18K | Sell |
365
-1,925
| -84% | -$94.9K | ﹤0.01% | 5212 |
|
2022
Q1 | $211K | Sell |
2,290
-532
| -19% | -$49K | ﹤0.01% | 4650 |
|
2021
Q4 | $626K | Sell |
2,822
-1,570
| -36% | -$348K | ﹤0.01% | 4197 |
|
2021
Q3 | $1.52M | Buy |
4,392
+2,157
| +97% | +$747K | ﹤0.01% | 3703 |
|
2021
Q2 | $840K | Buy |
2,235
+36
| +2% | +$13.5K | ﹤0.01% | 4083 |
|
2021
Q1 | $682K | Sell |
2,199
-536
| -20% | -$166K | ﹤0.01% | 4217 |
|
2020
Q4 | $685K | Buy |
2,735
+202
| +8% | +$50.6K | ﹤0.01% | 4224 |
|
2020
Q3 | $468K | Sell |
2,533
-537
| -17% | -$99.2K | ﹤0.01% | 4279 |
|
2020
Q2 | $768K | Sell |
3,070
-839
| -21% | -$210K | ﹤0.01% | 3915 |
|
2020
Q1 | $706K | Buy |
3,909
+2,698
| +223% | +$487K | ﹤0.01% | 3679 |
|
2019
Q4 | $505K | Sell |
1,211
-19,904
| -94% | -$8.3M | ﹤0.01% | 4260 |
|
2019
Q3 | $5.31M | Sell |
21,115
-8,320
| -28% | -$2.09M | ﹤0.01% | 2468 |
|
2019
Q2 | $11.7M | Buy |
29,435
+11,774
| +67% | +$4.68M | ﹤0.01% | 1840 |
|
2019
Q1 | $9.51M | Buy |
+17,661
| New | +$9.51M | ﹤0.01% | 1977 |
|